Aberrant inactivation of the mevalonate pathway has been reported to promote tumor progression and has a marked negative effect on YAP/TAZ transcriptional activity, as YAP/TAZ actions need mevalonate, geranylgeranyl pyrophosphate (GGPP) and Rho GTPases [30]. Here, YAP1 is linked to neoplasm.